Middle East and Africa Oxytocic Pharmaceuticals Market: By Product Type (Intramuscular Injection, Intravenous Injection), By Source (Natural Oxytocin (Animal Pituitary Extracts), Synthetic Oxytocin), By End-User (Maternity Clinics, Hospitals), and Country    

Purchase Option

$ 3000
$ 4400
$ 4600
$ 6900

 Oxytocin is a female reproductive hormone secreted in the hypothalamus and released into blood circulation during childbirth to induce the labor and milk production in mothers. It is also used as uterotonic (induce uterine contractions) and reduce the hemorrhage after C-section. Increase in the in the prevalence of post-partum hemorrhage due to lack of nutritious food supply to pregnant woman, rise in awareness about the pregnancy related conditions, escalation in complicated pregnancy cases, and rise in usage of oxytocin in maternity clinics are anticipated to boost the Middle East and Africa oxytocic pharmaceuticals market over the forecast years. However, adverse effects associated with oxytocic drugs may restrain the growth of market over the forecast period.


Middle East And Africa Oxytocic Pharmaceuticals Market Summary

Study Period


Base Year




Largest Market

Middle East and Africa

Fastest Growing Market


This oxytocic pharmaceutical market report includes information on new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localised market players, opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, and so on. For more information on the Data Bridge Market Research oxytocic pharmaceutical market, please contact us for an Analyst Brief; our team will assist you in making an informed market decision in order to achieve market growth.

Key Features of the Reports

  • The report provides granular level information about the market size, regional market share, historic market (2018 to 2022) and forecast (2023 to 2029)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market

Middle East And Africa Oxytocic Pharmaceuticals Market Segmentation

product type
  • Intramuscular Injection
  • Intravenous Injection
  • Natural Oxytocin (Animal Pituitary Extracts)
  • Synthetic Oxytocin
end user
  • Maternity Clinics
  • Hospitals
  • Gulf Cooperation Council (GCC) Countries
  • Israel
  • South Africa
  • Rest of MEA


Frequently Asked Questions

2021 is the base year and 2028 is the forecast year.

The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).

In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.

[urltag url='ask-an-analyst']

  • Pfizer, Inc. (U.S.)
  • Fresenius Kabi AG (Germany)
  • Novartis AG (Switzerland)
  • Cardinal Health (U.S.)
  • Par Pharmaceutical, Inc. (U.S.)